Alzheimer's Disease Treatment: The Search for a Breakthrough

Area of Science:

• Neuroscience
• Immunology
• Regenerative Medicine

Background:

• Current Alzheimer's disease (AD) treatments offer limited symptomatic relief and do not alter disease progression.
• Recently approved anti-amyloid therapies show uncertain real-world effectiveness and significant side effects.
• Focus is shifting towards early-stage interventions to preserve cognitive function and neuronal viability.

Purpose of the Study:

• To review pre-clinical experimental manipulations targeting neuroinflammation and neuro-regeneration for Alzheimer's disease.
• To explore novel therapeutic avenues beyond traditional approaches for AD management.

Main Methods:

• Overview of pre-clinical experimental strategies.
• Examination of pharmacologic interventions targeting neuroinflammation (e.g., microglial receptor inhibition, cytokine modulation).
• Evaluation of approaches like autophagy enhancement, microbiome-brain-gut axis modulation, dietary changes, and lifestyle interventions.

Main Results:

• Pre-clinical studies investigate inhibiting microglial receptors to reduce neuroinflammation.
• Enhancing autophagy is explored for improving toxin clearance in AD models.
• Modulating the microbiome-gut-brain axis and lifestyle factors are under investigation.

Conclusions:

• Novel therapeutic strategies targeting neuroinflammation and neuro-regeneration show promise for Alzheimer's disease.
• Early intervention and multi-faceted approaches, including lifestyle modifications, are crucial for preserving brain health.
• Collaborative efforts are essential to develop effective treatments to slow or halt AD progression.